6505--Perphenazine Tablets (VA-25-00037353)
ID: 36E79725R0030Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/ed2c131b08f24edbbb9c41640fcd5a14/view
Timeline
  1. 1
    Posted Apr 3, 2025, 12:00 AM UTC
  2. 2
    Updated Apr 3, 2025, 12:00 AM UTC
  3. 3
    Due Apr 24, 2025, 7:30 PM UTC
Description

The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to supply specified quantities of the drug to both the VA and the Department of Defense (DoD) through their Pharmaceutical Prime Vendor (PPV) Programs, with a focus on service-disabled veteran-owned small businesses, women-owned small businesses, and HUBZone small businesses. The procurement is critical for ensuring a consistent supply of pharmaceutical products while adhering to regulatory requirements, including the Drug Supply Chain Security Act (DSCSA) and FDA Good Manufacturing Practices (cGMP). Interested offerors must contact Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov for further details, and proposals must include a 0.5% Cost Recovery Fee and a unique National Drug Code (NDC) for each product.

Point(s) of Contact
Anthony DiCrescenzoContract Specialist
Anthony.DiCrescenzo@va.gov
Files
Title
Posted
36E79725R0030_1.docx
Mar 31, 2025, 2:04 PM UTC
The Department of Veterans Affairs (VA) is preparing to issue Request for Proposal (RFP) 36E79725R0030 for the procurement of Perphenazine Tablets. This is an unrestricted solicitation that will supply not only the VA but also the Department of Defense, the Bureau of Prisons, the Indian Health Service, and Federal Health Care Centers. The successful contractor will ensure a continuous supply for one year, with optional extensions for up to four additional years. The proposal is expected to be released electronically around April 10, 2025, with submissions due by April 24, 2025. Offerors must provide unique NDC numbers and specify the drug name as it appears on the label. The total estimated annual requirements consist of four variations of Perphenazine Tablets, with yearly needs quantified for each dosage. No paper copies of the solicitation will be distributed, and interested parties must keep informed of any updates on SAM.gov. All responsible sources are encouraged to submit a proposal, with primary inquiries directed to the point of contact, Anthony Di Crescenzo, via email.
36E79725R0030 - Final.docx
Apr 3, 2025, 6:05 PM UTC
The document details a government Request for Proposal (RFP) concerning the procurement of Perphenazine tablets for the Department of Veterans Affairs (VA) and Department of Defense (DoD) through their Pharmaceutical Prime Vendor (PPV) Programs. The solicitation outlines the requirements for service-disabled veteran-owned small businesses, women-owned small businesses, and HUBZone small businesses to compete for a contract to supply specified quantities of the drug across multiple years, including a base year and four option years. Offerors must provide pricing that includes a 0.5% Cost Recovery Fee and a unique National Drug Code (NDC) for each product. The contract is aimed at ensuring a consistent supply of pharmaceutical products, adhering to the Drug Supply Chain Security Act (DSCSA), and establishing a structured evaluation process based on Fair Acquisition Regulations (FAR). Moreover, the contractor must maintain compliance with FDA regulations, including Good Manufacturing Practices (cGMP). The contract's overall objective is to streamline the procurement and distribution process, allowing the VA and DoD to efficiently fulfill their pharmaceutical needs while maintaining regulatory compliance and cost-effectiveness.
Lifecycle
Title
Type
6505--Perphenazine Tablets (VA-25-00037353)
Currently viewing
Solicitation
6505--Perphenazine Tablets (VA-25-00037353)
Presolicitation
Similar Opportunities
6505--Topiramate Tablets (VA-25-00047941)
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Topiramate Tablets, designated as Solicitation 36E79725R0031. This procurement aims to secure an uninterrupted supply of various forms of Topiramate for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), highlighting the importance of ensuring continuous access to essential pharmaceuticals across federal health services. The contract will span one year with four additional pre-priced option years, and interested vendors must submit their proposals electronically by April 29, 2025, while providing the exact name of the drug along with a unique National Drug Code (NDC). For further inquiries, vendors can contact Contract Specialist Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.
6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg Tablets, which will serve various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract aims to ensure an uninterrupted supply of this essential medication for a period of one year, with options for four additional one-year terms, emphasizing the VA's commitment to maintaining critical pharmaceutical supplies. The estimated annual requirement is approximately 91,583 bottles, and interested offerors must ensure their product has a unique National Drug Code (NDC) and complies with specific packaging requirements, including safety caps. The solicitation is expected to be issued electronically on or around April 26, 2025, with a response deadline of May 13, 2025; inquiries can be directed to Deb Fassl at Deborah.Fassl@va.gov.
6505--Fludrocortisone Acetate Tablets (VA-25-00047932)
Buyer not available
The Department of Veterans Affairs is seeking offers for the procurement of Fludrocortisone Acetate Tablets (0.1 MG) under solicitation number 36E79725R0023, with an emphasis on compliance with federal regulations and pharmaceutical standards. Contractors are required to submit bids that include pricing for a base year and four option years, adhering to guidelines such as a 0.5% Cost Recovery Fee and compliance with the Drug Supply Chain Security Act. This procurement is crucial for ensuring a reliable supply of essential pharmaceuticals for veterans, reflecting the government's commitment to maintaining high standards in healthcare delivery. The deadline for submitting offers has been extended to April 21, 2025, at 2:30 PM Central Daylight Time, and interested parties should contact Contract Specialist Nicholas I McGregor at Nicholas.McGregor@va.gov for further information.
6505--Loperamide Capsules (VA-25-00032225)
Buyer not available
The Department of Veterans Affairs (VA) is seeking proposals for the procurement of Loperamide Hydrochloride (HCL) 2mg capsules, aimed at establishing a reliable supply source for pharmaceutical products to support healthcare services for veterans and other authorized users. Offerors must provide pricing for the base year and four additional one-year options, ensuring compliance with regulatory standards, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This procurement is critical for maintaining the quality and safety of pharmaceutical distribution to VA facilities and the Department of Defense through a network of Prime Vendors. Proposals are due by April 23, 2025, at 2:30 PM Central Time, and interested parties should contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
6505--Carvedilol Tablets (VA-25-00048048)
Buyer not available
The Department of Veterans Affairs is soliciting offers for the supply of Carvedilol Tablets under the solicitation titled '6505--Carvedilol Tablets (VA-25-00048048)'. This procurement aims to establish a reliable source for various types of Carvedilol Tablets over a base year and four option years, requiring offerors to submit pricing for all line items and ensure compliance with the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards. The initiative is critical for enhancing healthcare services for veterans and active duty military personnel, emphasizing the need for a Letter of Commitment from manufacturers and adherence to a structured delivery process. Interested parties can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov for further details regarding proposal submissions and compliance requirements.
6505--Ranolazine Sustained Action (SA) Tablets
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ranolazine Sustained Action (SA) Tablets, which will serve various federal entities, including the VA, Department of Defense, and Bureau of Prisons. The procurement aims to secure an uninterrupted supply of these pharmaceutical products, with specific requirements for labeling and packaging, including the necessity for a unique National Drug Code (NDC) and safety-cap standards. The estimated annual demand includes 229,028 bottles of 500 mg SA tablets and 95,925 bottles of 1000 mg SA tablets, with the contract expected to last one year, plus four optional one-year extensions. Interested offerors should monitor SAM.gov for updates and submit their proposals by May 6, 2025, with any inquiries directed to Contract Specialist Deb Fassl at Deborah.Fassl@va.gov.
6505--Buspirone RFP
Buyer not available
The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP 36E79725R0024) for the procurement of Buspirone HCL Tablets, which will serve the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). This unrestricted contract aims to ensure a consistent supply of various strengths of Buspirone HCL Tablets over a one-year period, with options for four additional one-year extensions, and requires offerors to provide the product's label name and a unique NDC number while adhering to specific packaging safety standards. The anticipated solicitation release date is April 8, 2025, with a response deadline set for April 23, 2025; interested parties should monitor the designated URL for updates, as no paper copies will be distributed. For inquiries, contact Amber Zavala at amber.zavala@va.gov or (708) 786-5245.
6505--Acyclovir Capsules (VA-25-00048078)
Buyer not available
The Department of Veterans Affairs is seeking proposals for the procurement of Acyclovir Capsules, specifically 200MG capsules in two packaging sizes, to support the healthcare needs of veterans. The solicitation includes two line items: Line Item 1 requires 3,256 bottles of 100 capsules per bottle, and Line Item 2 requests 15,475 bottles of 500 capsules per bottle, with the same quantities needed for the base year and each of the four option years. This procurement is crucial for ensuring a reliable supply of essential pharmaceuticals for veterans, emphasizing the importance of compliance and competition within the pharmaceutical supply chain. Interested suppliers must submit their pricing proposals by May 1, 2025, and can contact Contracting Officer Andrew Cazares at andrew.cazaeres@va.gov or (708) 786-4990 for further details.
6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
Buyer not available
The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77025Q0202 760-25-2-050-0921 OM PHARM A1325, A0606 EMERGENCY (VA-25-00066272)
Buyer not available
The Department of Veterans Affairs is seeking small business contractors to fulfill an emergency procurement of pharmaceuticals for the VA CMOP facility in Leavenworth, Kansas. The requirement includes specific medications, notably Amlodipine and Benazepril capsules, with a total quantity of 1,536 units to be delivered within 10 days after receipt of order. This procurement is critical for addressing urgent healthcare needs for veterans and is subject to the Buy American statute, necessitating compliance with domestic sourcing requirements. Interested vendors must submit their quotes, including a signed solicitation cover page, a state wholesale distributor license, and a completed Buy American certificate, by April 16, 2025, to Jeffrey Blackard at Jeffrey.Blackard@va.gov.